AlloClae procedure faces legal dispute over human fat fillers

A legal dispute has emerged in the United States regarding AlloClae, an aesthetic procedure that uses processed and sterilized human fat from deceased donors as a filler. Developed by Tiger Aesthetics and launched in 2024, the procedure is marketed as a rapid, non-surgical alternative to traditional implants or liposuction, with costs ranging from $10,000 to $100,000.

Patients have reported severe side effects. One California resident, identified as Nicole, reported developing hard nodules and oily cysts after paying $10,000 for the procedure, describing the texture of her breasts as resembling the ‘surface of the moon.’ Other patients have also reported the development of cysts, contributing to a growing wave of regret online.